Home › Free Stock Grades › CBLL
CeriBell, Inc. (CBLL) Stock Grade
CBLL · Healthcare
C
Market Cap
$930.0M
P/E Ratio
—
Revenue Growth (YoY)
+36.1%
Net Margin
-60.0%
Return on Equity
—
Dividend Yield
None
About CeriBell, Inc.'s fundamentals
CeriBell is a medical device company with a $930.0M market cap that is experiencing strong revenue expansion, growing 36.1% year-over-year. However, the company is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -60.0%, indicating it is spending significantly more than it generates in revenue. The company does not pay a dividend and lacks sufficient profitability metrics for traditional valuation analysis. This profile is typical of an early-stage or growth-stage medical device maker that is prioritizing expansion over profitability.